Press releases
- Press releases
- Browse
Press releases
Hamburg, December 10th, 2010
Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development company in Buenos Aires, Argentina.
Amarin h More
Effective September 28th, 2010, Hamburg based HELM AG has purchased a 30% shareholding in Amarin Technologies S.A. a privately owned pharmaceutical development company in Buenos Aires, Argentina.
Amarin h More
APR, the drug developer and drug delivery technology provider headquartered in Balerna, Switzerland and its partner Labtec, the drug delivery technology developer headquartered in Langenfeld, Germany announce the submission of Zolmitriptan Oral Dispersibl More
GlaxoSmithKline obtains exclusive rights for an innovative topical patch to treat cold sores More
Related Reports
Market Research Reports provided by reports.iptechex.com
Sep 2011 - 39 pages - $250
Sep 2011 - 40 pages - $250
Sep 2011 - 42 pages - $250
Sep 2011 - 43 pages - $250
Sep 2010 - 37 pages - $250
Sep 2011 - 45 pages - $250
Jan 2011 - 20 pages - $340
Jan 2011 - 54 pages - $340
Oct 2010 - 112 pages - $7,600
Sep 2011 - 42 pages - $250
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us